For the year ending 2025-12-31, VYNE has $30,160K in assets. $2,395K in debts. $24,027K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 24,027 | |||
| Investment in marketable securities (note 6) | 4,981 | |||
| Prepaid and other current assets | 1,002 | |||
| Total current assets | 30,010 | |||
| Property and equipment, net (note 7) | 90 | |||
| Operating lease right of use assets (note 9) | 0 | |||
| Non-current prepaid expenses and other assets | 60 | |||
| Total non-current assets | 150 | |||
| Total assets | 30,160 | |||
| Trade payables | 1,041 | |||
| Accrued expenses (note 8) | 941 | |||
| Employee-related obligations | 413 | |||
| Operating lease liabilities (note 9) | 0 | |||
| Other current liabilities | 0 | |||
| Total current liabilities | 2,395 | |||
| Total liabilities | 2,395 | |||
| Common stock 0.0001 par value 150,000,000 shares authorized at december31, 2025 and december31, 2024 33,323,171 and 14,830,013 shares issued and outstanding at december31, 2025 and 2024, respectively | 3 | |||
| Additional paid-in capital | 785,413 | |||
| Accumulated other comprehensive income | 2 | |||
| Accumulated deficit | -757,653 | |||
| Total shareholders' equity | 27,765 | |||
| Total liabilities and shareholders equity | 30,160 | |||
VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Inc. (VYNE)